Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer Abandons New R&D Site

by Lisa M. Jarvis
July 13, 2009 | A version of this story appeared in Volume 87, Issue 28

Pfizer has jettisoned plans to move roughly 100 employees into a new R&D space in San Francisco's Mission Bay area. The plan to locate the global headquarters of its Biotherapeutics & Bioinnovation Center (BBC) was announced last August in a groundbreaking ceremony that included San Francisco Mayor Gavin Newsom, biotech consultant G. Steven Burrill, and BBC President Corey Goodman. In subsequent months, Pfizer acquired Wyeth, which has a substantial biotherapeutics presence, and Goodman left the company.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.